Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VX-103 by Vaxess Technologies for Influenza A Virus, H1N1 Subtype Infections: Likelihood of Approval
VX-103 is under clinical development by Vaxess Technologies and currently in Phase I for Influenza A Virus, H1N1 Subtype Infections....
Data Insights
VX-103 by Vaxess Technologies for Seasonal Influenza: Likelihood of Approval
VX-103 is under clinical development by Vaxess Technologies and currently in Phase I for Seasonal Influenza. According to GlobalData, Phase...